Cairo – Mubasher: The unaudited financial results of Arab Drug Company showed a 20.47% year-on-year (YoY) rise in its net profits before taxes, logging EGP 72.62 million in the first half (H1) of fiscal year 2020/2021, compared to EGP 60.28 million in the year-ago period.
The company generated EGP 292.14 million in revenue in the July-December period, up from EGP 271.8 million in the corresponding period a year earlier, according to a bourse disclosure on Tuesday.
During the first quarter (Q1) of FY20/21, Arab Drug Company reported EGP 35.56 million in net profits before taxes, up from EGP 25.39 in the prior-year period.
